Corticosteroids for bacterial keratitis: The steroids for corneal ulcers trial (SCUT)

Archives of Ophthalmology

Volumn 130, Issue 2, 2012, Pages 143-150

  Srinivasan, Muthiah ^a   Mascarenhas, Jeena ^a   Rajaraman, Revathi ^a   Ravindran, Meenakshi ^a   Lalitha, Prajna ^a   Glidden, David V ^c   Ray, Kathryn J ^b   Hong, Kevin C ^b   Oldenburg, Catherine E ^b   Lee, Salena M ^b   Zegans, Michael E ^d   McLeod, Stephen D ^b,c   Lietman, Thomas M ^b,c   Acharya, Nisha R ^b,c  

^a ARAVIND EYE CARE SYSTEM   (India)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; PLACEBO; PREDNISOLONE SODIUM PHOSPHATE;

ADULT; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA PERFORATION; CORNEA THINNING; CORNEA ULCER; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; ENDOPHTHALMITIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HYPOPYON; INFECTION; INTRAOCULAR PRESSURE; KERATITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REEPITHELIALIZATION; SCAR; SIDE EFFECT; TREATMENT OUTCOME; VISION; VISUAL ACUITY; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIA; CORNEA; CORNEAL ULCER; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREDNISOLONE; QUINOLINES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84863133408     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2011.315     Document Type: Article

References (31)

1. Acharya NR, Srinivasan M, Mascarenhas J, et al. The steroid controversy in bacterial keratitis. Arch Ophthalmol. 2009;127(9):1231.
2. Cohen EJ. The case against the use of steroids in the treatment of bacterial keratitis. Arch Ophthalmol. 2009;127(1):103-104.
3. Hindman HB, Patel SB, Jun AS. Rationale for adjunctive topical corticosteroids in bacterial keratitis. Arch Ophthalmol. 2009;127(1):97-102.
4. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997;99(2):226-231. (Pubitemid 27148875)
5. Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989; 8(12):848-851. (Pubitemid 20018839)
6. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al. Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med. 1988;319(15):964-971.
7. American Academy of Ophthalmology Cornea/External Disease Panel. Preferred Practice Pattern Guidelines: Bacterial Keratitis. San Francisco, CA: American Academy of Ophthalmology; 2008.
8. Carmichael TR, Gelfand Y, Welsh NH. Topical steroids in the treatment of central and paracentral corneal ulcers. Br J Ophthalmol. 1990;74(9):528-531. (Pubitemid 20265397)
9. Srinivasan M, Lalitha P, Mahalakshmi R, et al. Corticosteroids for bacterial corneal ulcers. Br J Ophthalmol. 2009;93(2):198-202.
10. Blair J, Hodge W, Al-Ghamdi S, et al. Comparison of antibiotic-only and antibiotic-steroid combination treatment in corneal ulcer patients: double-blinded randomized clinical trial. Can J Ophthalmol. 2011;46(1):40-45.
11. Srinivasan M, Mascarenhas J, Rajaraman R, et al. The Steroids for Corneal Ulcers Trial: study design and baseline characteristics [published online October 10, 2011]. Arch Ophthalmol. doi:10.1001/archophthalmol.2011.303.
12. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128(6):672-678.
13. Vittinghoff E, Glidden D, Shiboski S, McCulloch CE. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer; 2005.
14. Badenoch PR, Hay GJ, McDonald PJ, Coster DJ. A rat model of bacterial keratitis: effect of antibiotics and corticosteroid. Arch Ophthalmol. 1985;103(5):718-722. (Pubitemid 15052413)
15. Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1995;14(3):229-234.
16. Hobden JA, Engel LS, Hill JM, Callegan MC, O'Callaghan RJ. Prednisolone acetate or prednisolone phosphate concurrently administered with ciprofloxacin for the therapy of experimental Pseudomonas aeruginosa keratitis. Curr Eye Res. 1993;12(5):469-473. (Pubitemid 23206226)
17. Hobden JA, Hill JM, Engel LS, O'Callaghan RJ. Age and therapeutic outcome of experimental Pseudomonas aeruginosa keratitis treatedwith ciprofloxacin, prednisolone, and flurbiprofen. Antimicrob Agents Chemother. 1993;37(9):1856-1859. (Pubitemid 23265542)
18. Suie T, Taylor FW. The effect of cortisone on experimental Pseudomonas corneal ulcers. AMA Arch Ophthalmol. 1956;56(1):53-56.
19. Coster DJ, Badenoch PR. Host, microbial, and pharmacological factors affecting the outcome of suppurative keratitis. Br J Ophthalmol. 1987;71(2):96-101. (Pubitemid 17009920)
20. Smolin G, Okumoto M, Leong-Sit L. Combined gentamicin-tobramycin- corticosteroid treatment, II: effect on gentamicin-resistant Pseudomonas keratitis. Arch Ophthalmol. 1980;98(3):473-474. (Pubitemid 10133643)
21. Wilhelmus KR. Indecision about corticosteroids for bacterial keratitis: an evidencebased update. Ophthalmology. 2002;109(5):835-843.
22. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999; 106(6):1166-1171. (Pubitemid 30191521)
23. Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol. 2003;87(7):834-838. (Pubitemid 36765243)
24. Dunlop AA, Wright ED, Howlader SA, et al. Suppurative corneal ulceration in Bangladesh: a study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z JOphthalmol. 1994;22(2):105-110. (Pubitemid 24270343)
25. Keay L, Edwards K, Naduvilath T, et al. Microbial keratitis predisposing factors and morbidity. Ophthalmology. 2006;113(1):109-116. (Pubitemid 43021736)
26. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea. 2008;27(1):33-39.
27. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002; 86(11):1211-1215. (Pubitemid 35238594)
28. van der Meulen IJ, van Rooij J, Nieuwendaal CP, Van Cleijnenbreugel H, Geerards AJ, Remeijer L. Age-related risk factors, culture outcomes, and prognosis in patients admitted with infectious keratitis to two Dutch tertiary referral centers. Cornea. 2008;27(5):539-544.
29. Varaprasathan G, Miller K, Lietman T, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23(4):360-364. (Pubitemid 38544052)
30. Hsu HY, Nacke R, Song JC, Yoo SH, Alfonso EC, Israel HA. Community opinions in the management of corneal ulcers and ophthalmic antibiotics: a survey of 4 states. Eye Contact Lens. 2010;36(4):195-200.
31. Chen A, Prajna L, Srinivasan M, et al. Does in vitro susceptibility predict clinical outcome in bacterial keratitis? Am J Ophthalmol. 2008;145(3):409-412.